First Personal Financial Services Sells 1,674 Shares of The Clorox Company (NYSE:CLX)

First Personal Financial Services lowered its stake in shares of The Clorox Company (NYSE:CLX) by 5.0% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 32,056 shares of the company’s stock after selling 1,674 shares during the period. First Personal Financial Services’ holdings in Clorox were worth $5,222,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of CLX. Mizuho Markets Americas LLC increased its position in shares of Clorox by 93.7% during the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock valued at $11,032,000 after purchasing an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its position in shares of Clorox by 15.2% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after purchasing an additional 18,687 shares during the last quarter. Advisors Asset Management Inc. increased its position in shares of Clorox by 257.5% during the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after purchasing an additional 8,087 shares during the last quarter. Catalyst Capital Advisors LLC purchased a new stake in shares of Clorox during the 3rd quarter valued at about $54,000. Finally, Raymond James & Associates increased its position in shares of Clorox by 32.8% during the 2nd quarter. Raymond James & Associates now owns 267,632 shares of the company’s stock valued at $36,524,000 after purchasing an additional 66,149 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.5 %

CLX opened at $165.16 on Friday. The firm has a 50-day simple moving average of $162.14 and a two-hundred day simple moving average of $146.83. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $169.09. The company has a market capitalization of $20.44 billion, a PE ratio of 57.55, a price-to-earnings-growth ratio of 3.01 and a beta of 0.41. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s revenue was up 27.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 EPS. Analysts forecast that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.95%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio is 170.04%.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.57% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the subject of several research reports. DA Davidson upped their price target on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Evercore ISI decreased their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday. Finally, JPMorgan Chase & Co. upped their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.